Vor Biopharma Inc. (VOR) - Latest Market Data

Price & Market Data

Price: $16.44

Daily Change: -$0.81 / 4.93%

Daily Range: $15.47 - $17.20

Market Cap: $892,439,040

Daily Volume: 1,225,089

Performance Metrics

1 Week: 6.12%

1 Month: 3.13%

3 Months: 18.57%

6 Months: -11.93%

1 Year: 377.4%

YTD: 25.92%

About Vor Biopharma Inc. (VOR)

Get a quick summary of Vor Biopharma Inc. (VOR). The stock is priced at 16.44, experiencing a -$0.81 / 4.93% daily shift. Its market capitalization stands at 892,439,040. Track its performance from the last 3 months (18.57%) to the entire year (377.4%).

Company Details

Employees: 76

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Selected stocks

MetroCity Bankshares, Inc. (MCBS)

MUELLER WATER PRODUCTS (MWA)

Synthetic Fixed-Income Securities, Inc. on behalf of STRATS (SM) Trust for Dominion Resources, Inc. Securities, Series 2 (GJP)

QUALCOMM Incorporated (QCOM)